Programmable genome editors are enzymes that can be targeted
to
a specific location in the genome for making site-specific alterations
or deletions. The engineering, design, and development of sequence-specific
editors has resulted in a dramatic increase in the precision of editing
for nucleotide sequences. These editors can target specific locations
in a genome, in vivo. The genome editors are being
deployed for the development of genetically modified organisms for
agriculture and industry, and for gene therapy of inherited human
genetic disorders, cancer, and immunotherapy. Experimental and computational
studies of structure, binding, activity, dynamics, and folding, reviewed
here, have provided valuable insights that have the potential for
increasing the functional efficiency of these gene/genome editors.
Biochemical and biophysical studies of the specificities of natural
and engineered genome editors reveal that increased binding affinity
can be detrimental because of the increase of off-target effects and
that the engineering and design of genome editors with higher specificity
may require modulation and control of the conformational dynamics.